Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 347 of 1,261
  1. US 10994055

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  2. US 10994031

    Composites and compositions for therapeutic use and methods of making and using the same

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  3. US 10995089

    Zaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  4. US 10993967

    Combinatorial cancer immunotherapy

    Senti Biosciences, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  5. US 10994016

    Graphene oxide mediated cellular delivery of gadolinium-labeled molecules

    Northwestern University · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  6. US 10993999

    Materials and methods for producing improved lentiviral vector particles

    IMMUNE DESIGN CORP. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  7. US 10993983

    Cyclic peptide epitopes and small-molecule mimics for inducing autophagy

    The Board of Regents of the University of Texas System · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  8. US 10993956

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  9. US 10993938

    Lactam compound, preparation method and use thereof

    OCEAN UNIVERSITY OF CHINA · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  10. US 10993941

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  11. US 10993930

    Methods and materials for using Ruminococcus gnavus or Clostridium sporogenes to treat gastrointestinal disorders

    The Regents of the University of California · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  12. US 10993876

    Pharmaceutical compounding methods and systems

    MEDISCA PHARMACEUTIQUE INC. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  13. US 10993834

    Lacrimal system drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  14. US 10993843

    Head trauma bandage cap and method

    First Responder Solutions, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  15. US 10994019

    Bicyclic peptide-toxin conjugates specific for MT1-MMP

    BicycleRD Limited · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  16. US 10988780

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  17. US 10987281

    Self-adhesive dental composite resin

    KURARAY NORITAKE DENTAL INC. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  18. US 10988734

    Methods for preparing therapeutically active cells using microfluidics

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  19. US 10988778

    Codon-optimized reduced-size ATP7A cDNA and uses for treatment of copper transport disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  20. US 10988538

    Bispecific signaling agents and uses thereof

    Orionis Biosciences, Inc · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  21. US 10988763

    Single-stranded RNA-editing oligonucleotides

    ProQR Therapeutics II B.V. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  22. US 10988477

    GCN2 inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  23. US 10988748

    Compositions and methods for treating celiac sprue disease

    The Regents of the University of California · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  24. US 10988470

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.